Natural medicines-derived carbon dots as novel oral antioxidant administration strategy for ulcerative colitis therapy
Journal of Nanobiotechnology · 2024
DOI: 10.1186/s12951-024-02702-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nanobiotechnology, 2024. Verfasst von Tong Wu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Carbon, Antioxidants. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Grant for Qihuang Scholars of the state administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Ulcerative colitis (UC) is a chronic intestinal inflammation, resulting in a global healthcare challenge with no real specific medicine. Natural medicines are recognized as a potential clinical alternative therapy, but their applications are limited by poor solubility and low bioavailability.
Results
In this work, inspired by the natural medicines of ancient China, novel functional carbon dots derived from Magnetite and Medicated Leaven (MML-CDs) were synthesized by hydrothermal method, and confirmed their ultrasmall nano-size (3.2 ± 0.6 nm) and Fe doped surface structure, thereby with excellent gastrointestinal stability, remarkable capabilities in eliminating ROS, and highly biocompatibility. With no external stimuli, the oral administration of MML-CDs demonstrated obvious alleviation to UC. Further experiments pointed that MML-CDs could improve hemostasis capability, suppress inflammation reactions and oxidative stress, and up-regulate the expression of tight junction proteins. Furthermore, MML-CDs also showed well regulation in the dysbiosis of intestinal flora.
Conclusion
Overall, above evidence reveals that green-synthesized MML-CDs can significantly alleviate intestinal bleeding, inhibit colon inflammation, and repair colonic barrier damage, further regulating intestinal flora and intestinal inflammation microenvironment. Our findings provide an efficient oral administration of MML-CDs as a novel therapy strategy for ulcerative colitis. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.
- School of Life Science, Beijing University of Chinese Medicine, Beijing, 100029, China.
- Qingdao Eighth People's Hospital, Qingdao, 266100, China.
- Department of Endocrine, Beijing Daxing District Hospital of Integrated Chinese and Western Medicine, Beijing, 100163, China.
- Department of Traditional Chinese Medicine, Beijing Daxing District Hospital of Integrated Chinese and Western Medicine, Beijing, 100163, China.
Förderung
- the Grant for Qihuang Scholars of the state administration of Traditional Chinese Medicine
Zitieren
APA
Wu, T., Bai, X., Zhang, Y., Dai, E., Ma, J., Yu, C., He, C., Li, Q., Yang, Y., Kong, H., Qu, H., & Zhao, Y. (2024). Natural medicines-derived carbon dots as novel oral antioxidant administration strategy for ulcerative colitis therapy. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-024-02702-2
Vancouver
Wu T, Bai X, Zhang Y, Dai E, Ma J, Yu C, et al. Natural medicines-derived carbon dots as novel oral antioxidant administration strategy for ulcerative colitis therapy. Journal of Nanobiotechnology. 2024. doi:10.1186/s12951-024-02702-2
BibTeX
@article{Wu2024,
author = {Wu, Tong and Bai, Xue and Zhang, Yue and Dai, Ertong and Ma, Jinyu and Yu, Cai and He, Chenxin and Li, Qiannan and Yang, Yingxin and Kong, Hui and Qu, Huihua and Zhao, Yan},
title = {Natural medicines-derived carbon dots as novel oral antioxidant administration strategy for ulcerative colitis therapy},
journal = {Journal of Nanobiotechnology},
year = {2024},
doi = {10.1186/s12951-024-02702-2}
}
EUVIMED